MedTrace Logo

EUREKA Italy - Evaluation of Real-life Use of KLOX BioPhotonic System in Chronic Wounds Management

NCT03021811 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2017-08-18

No results posted yet for this study

Summary

Multi-center, prospective, interventional, uncontrolled open-label study evaluating the real-life use of KLOX LumiHeal BioPhotonic System in chronic wounds management (venous leg ulcers, diabetic foot ulcers, pressure ulcers).

Conditions

  • Venous Leg Ulcer
  • Diabetic Foot Ulcer
  • Pressure Ulcer

Interventions

DEVICE

KLOX LumiHeal BioPhotonic System

Real-life use of KLOX LumiHeal BioPhotonic System in combination with standard of care.

Sponsors & Collaborators

  • KLOX Technologies Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2016-12-31
Completion
2017-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03021811 on ClinicalTrials.gov